Advanced search
Publication Cover
Expert Review of Proteomics Volume 5, 2008 - Issue 2
Submit an article Journal homepage
283
Views
40
CrossRef citations to date
0
Altmetric
Review

Targeted proteomics in Alzheimer’s disease: focus on amyloid-β

Erik Portelius Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy at Göteborg University, Mölndal, Sweden. [email protected]
,
Henrik Zetterberg Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy at Göteborg University, Mölndal, Sweden. [email protected]
,
Johan Gobom Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy at Göteborg University, Mölndal, Sweden. [email protected]
,
Ulf Andreasson Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy at Göteborg University, Mölndal, Sweden. [email protected]
&
Kaj Blennow Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy at Göteborg University, S-431 80 Mölndal, Sweden. [email protected]
Pages 225-237 | Published online: 09 Jan 2014

Citations (40)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Erik Portelius, Gunnar Brinkmalm, Josef Pannee, Henrik Zetterberg, Kaj Blennow, Rahil Dahlén, Ann Brinkmalm & Johan Gobom. (2017) Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer’s disease: an update. Expert Review of Proteomics 14:11, pages 1007-1020.
Read now
Mojtaba Ansari, Mehran Habibi-Rezaei, Soheila Salahshour-Kordestani, Maryam Ferdousi & Ali Akbar Moosavi Movahedi. (2016) An investigation on the effect of β-CD modified Fe3O4 magnetic nanoparticles on aggregation of amyloid b peptide (25-35). Materials Technology 31:6, pages 315-321.
Read now
Alessia Tarditi, Andrea Caricasole & Georg Terstappen. (2009) Therapeutic targets for Alzheimer's disease. Expert Opinion on Therapeutic Targets 13:5, pages 551-567.
Read now

Articles from other publishers (37)

Maryam Behzad, Negin Zirak, Ghazal Hamidi Madani, Linda Baidoo, Ali Rezaei, Shima Karbasi, Mohammad Sadeghi, Mahan Shafie, Mahsa Mayeli & Alzheimer’s Disease Neuroimaging Initiative. (2023) CSF-Targeted Proteomics Indicate Amyloid-Beta Ratios in Patients with Alzheimer’s Dementia Spectrum. International Journal of Alzheimer's Disease 2023, pages 1-9.
Crossref
Agueda Rostagno, Erwin Cabrera, Tammaryn Lashley & Jorge Ghiso. (2022) N-terminally truncated Aβ4-x proteoforms and their relevance for Alzheimer’s pathophysiology. Translational Neurodegeneration 11:1.
Crossref
Nishit Pathak, Sunil Kumar Vimal, Ishi Tandon, Lokesh Agrawal, Cao Hongyi & Sanjib Bhattacharyya. (2021) Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment. Metabolic Brain Disease 37:1, pages 67-104.
Crossref
Eleni Gkanatsiou, Charlotte Sahlin, Erik Portelius, Malin Johannesson, Linda Söderberg, Johanna Fälting, Hans Basun, Christer Möller, Tomas Odergren, Henrik Zetterberg, Kaj Blennow, Lars Lannfelt & Gunnar Brinkmalm. (2021) Characterization of monomeric and soluble aggregated Aβ in Down’s syndrome and Alzheimer’s disease brains. Neuroscience Letters 754, pages 135894.
Crossref
Ann Brinkmalm, Erik Portelius, Gunnar Brinkmalm, Josef Pannee, Rahil Dahlén, Johan Gobom, Kaj Blennow & Henrik Zetterberg. (2018) Fluid‐based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases. Journal of Neurochemistry 151:4, pages 417-434.
Crossref
Ava Faridi, Yunxiang Sun, Monika Mortimer, Ritchlynn R. Aranha, Aparna Nandakumar, Yuhuan Li, Ibrahim Javed, Aleksandr Kakinen, Qingqing Fan, Anthony W. Purcell, Thomas P. Davis, Feng Ding, Pouya Faridi & Pu Chun Ke. (2019) Graphene quantum dots rescue protein dysregulation of pancreatic β-cells exposed to human islet amyloid polypeptide. Nano Research 12:11, pages 2827-2834.
Crossref
Giuseppe Grasso. (2018) Mass spectrometry is a multifaceted weapon to be used in the battle against Alzheimer's disease: Amyloid beta peptides and beyond. Mass Spectrometry Reviews 38:1, pages 34-48.
Crossref
Erwin Cabrera, Paul Mathews, Emiliya Mezhericher, Thomas G. Beach, Jingjing Deng, Thomas A. Neubert, Agueda Rostagno & Jorge Ghiso. (2018) Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:1, pages 208-225.
Crossref
Isidro Ferrer. 2018. Brain Banking. Brain Banking 285 302 .
Mitsuru Shinohara, Shunsuke Koga, Takuya Konno, Jeremy Nix, Motoko Shinohara, Naoya Aoki, Pritam Das, Joseph E Parisi, Ronald C Petersen, Terrone L Rosenberry, Dennis W Dickson & Guojun Bu. (2017) Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer’s disease. Brain 140:12, pages 3301-3316.
Crossref
Antoni Bayes-Genis, Jaume Barallat, Marta de Antonio, Mar Domingo, Elisabet Zamora, Joan Vila, Isaac Subirana, Paloma Gastelurrutia, M. Cruz Pastor, James L. Januzzi & Josep Lupón. (2017) Amiloide beta (1-40) en sangre, cognición y pronóstico en insuficiencia cardiaca. Revista Española de Cardiología 70:11, pages 924-932.
Crossref
Antoni Bayes-Genis, Jaume Barallat, Marta de Antonio, Mar Domingo, Elisabet Zamora, Joan Vila, Isaac Subirana, Paloma Gastelurrutia, M. Cruz Pastor, James L. Januzzi & Josep Lupón. (2017) Bloodstream Amyloid-beta (1-40) Peptide, Cognition, and Outcomes in Heart Failure. Revista Española de Cardiología (English Edition) 70:11, pages 924-932.
Crossref
Ozlem Gursoy Calan, Pinar Akan, Aysenur Cataler, Cumhur Dogan & Semra Kocturk. (2016) Amyloid Beta Peptides Affect Pregnenolone and Pregnenolone Sulfate Levels in PC-12 and SH-SY5Y Cells Depending on Cholesterol. Neurochemical Research 41:7, pages 1700-1712.
Crossref
Tobias Bittner, Henrik Zetterberg, Charlotte E. Teunissen, Richard E. OstlundJr.Jr., Michael Militello, Ulf Andreasson, Isabelle Hubeek, David Gibson, David C. Chu, Udo Eichenlaub, Peter Heiss, Uwe Kobold, Andreas Leinenbach, Kairat Madin, Ekaterina Manuilova, Christina Rabe & Kaj Blennow. (2015) Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β‐amyloid (1–42) in human cerebrospinal fluid. Alzheimer's & Dementia 12:5, pages 517-526.
Crossref
Simone Lista, Zaven S. Khachaturian, Dan Rujescu, Francesco Garaci, Bruno Dubois & Harald Hampel. 2016. Systems Biology of Alzheimer's Disease. Systems Biology of Alzheimer's Disease 49 67 .
Mar Hernandez-Guillamon, Stephanie Mawhirt, Steven Blais, Joan Montaner, Thomas A. Neubert, Agueda Rostagno & Jorge Ghiso. (2015) Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9. Journal of Biological Chemistry 290:24, pages 15078-15091.
Crossref
Pauline Bros, Vincent Delatour, Jérôme Vialaret, Béatrice Lalere, Nicolas Barthelemy, Audrey Gabelle, Sylvain Lehmann & Christophe Hirtz. (2015) Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications. Clinical Chemistry and Laboratory Medicine (CCLM) 53:10.
Crossref
Andrew J. Percy, Juncong Yang, Andrew G. Chambers, Romain Simon, Darryl B. Hardie & Christoph H. Borchers. (2014) Multiplexed MRM with Internal Standards for Cerebrospinal Fluid Candidate Protein Biomarker Quantitation. Journal of Proteome Research 13:8, pages 3733-3747.
Crossref
Clara Ibáñez, Alberto Valdés, Virginia García-Cañas & Carolina Simó. 2014. Applications of Advanced Omics Technologies: From Genes to Metabolites. Applications of Advanced Omics Technologies: From Genes to Metabolites 249 278 .
Sylvain Lehmann, Andrew Hoofnagle, Denis Hochstrasser, Cato Brede, Matthias Glueckmann, José A. Cocho, Uta Ceglarek, Christof Lenz, Jérôme Vialaret, Alexander Scherl & Christophe Hirtz. (2013) Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application. Clinical Chemistry and Laboratory Medicine 51:5.
Crossref
Ulf Andreasson, Erik Portelius, Josef Pannee, Henrik Zetterberg & Kaj Blennow. (2012) Multiplexing and multivariate analysis in neurodegeneration. Methods 56:4, pages 464-470.
Crossref
Anders M. Fjell & Kristine B. Walhovd. (2011) Neuroimaging Results Impose New Views on Alzheimer’s Disease—the Role of Amyloid Revised. Molecular Neurobiology 45:1, pages 153-172.
Crossref
Alexander V. LyubimovAlexandra van Remoortere, Emrys A. Jones, André M. Deelder & Liam A. McDonnell. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 41 .
Anders M. Fjell & Kristine B. Walhovd. (2011) New Tools for the Study of Alzheimer’s Disease. The Neuroscientist 17:5, pages 592-605.
Crossref
Erik Portelius, Eric Price, Gunnar Brinkmalm, Mark Stiteler, Maria Olsson, Rita Persson, Ann Westman-Brinkmalm, Henrik Zetterberg, Adam J. Simon & Kaj Blennow. (2011) A novel pathway for amyloid precursor protein processing. Neurobiology of Aging 32:6, pages 1090-1098.
Crossref
Gábor Juhász, István Földi & Botond Penke. (2011) Systems biology of Alzheimer's disease: How diverse molecular changes result in memory impairment in AD. Neurochemistry International 58:7, pages 739-750.
Crossref
Giuseppe Grasso. (2011) The use of mass spectrometry to study amyloid-β peptides. Mass Spectrometry Reviews 30:3, pages 347-365.
Crossref
Christian Humpel. (2011) Cerebrospinal fluid and blood biomarkers in Alzheimer’s disease. World Journal of Psychiatry 1:1, pages 8.
Crossref
Erik Portelius, Ulf Andreasson, John M Ringman, Katharina Buerger, Jonny Daborg, Peder Buchhave, Oskar Hansson, Andreas Harmsen, Mikael K Gustavsson, Eric Hanse, Douglas Galasko, Harald Hampel, Kaj Blennow & Henrik Zetterberg. (2010) Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1A431E-associated familial Alzheimer's disease. Molecular Neurodegeneration 5:1.
Crossref
Per Selnes, Kaj Blennow, Henrik Zetterberg, Ramune Grambaite, Lars Rosengren, Lisbeth Johnsen, Vidar Stenset & Tormod Fladby. (2010) Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid. Cerebrospinal Fluid Research 7:1.
Crossref
Sze-Ming Chua, Beng-Yeong Ng & Tih-Shih Lee. (2010) Genetic and Genomic Aspects of Alzheimer's Disease. Proceedings of Singapore Healthcare 19:4, pages 334-341.
Crossref
Chenggang Zhang. (2010) Proteomic Studies on the Development of the Central Nervous System and Beyond. Neurochemical Research 35:10, pages 1487-1500.
Crossref
Cuiying Chitty ChenSebastiaan EngelborghsSylviane DewaeleNathalie Le BastardJean-Jacques MartinValerie VanhoorenClaude LibertPeter Paul De Deyn. (2010) Altered Serum Glycomics in Alzheimer Disease: A Potential Blood Biomarker?. Rejuvenation Research 13:4, pages 439-444.
Crossref
Alexandra AbramssonAnn Westman-BrinkmalmJosef PanneeMikael GustavssonMalin von OtterKaj BlennowGunnar BrinkmalmPetronella KettunenHenrik Zetterberg. (2010) Proteomics Profiling of Single Organs from Individual Adult Zebrafish. Zebrafish 7:2, pages 161-168.
Crossref
Minna A. Korolainen, Tuula A. Nyman, Tero Aittokallio & Tuula Pirttilä. (2010) An update on clinical proteomics in Alzheimer’s research. Journal of Neurochemistry 112:6, pages 1386-1414.
Crossref
Niklas Mattsson, Kaj Blennow & Henrik Zetterberg. (2009) CSF Biomarkers. Annals of the New York Academy of Sciences 1180:1, pages 28-35.
Crossref
Paul W. Thompson & Andrew Lockhart. (2009) Monitoring the amyloid beta-peptide in vivo – caveat emptor. Drug Discovery Today 14:5-6, pages 241-251.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.